|
1) Braith RW, Stewart KJ. Resistance exercise training: its role in the prevention of cardiovascular disease. Circulation. 2006; 113: 2642-50
|
|
|
|
2) Narkar VA, Downes M, Yu RT, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell. 2008; 134: 405-15
|
|
|
|
|
|
3) Wang YX, Zhang CL, Yu RT, et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2004; 2: e294
|
|
|
|
|
|
4) Ishii T, Yamakita T, Sato T, et al. Resistance training improves insulin sensitivity in NIDDM subjects without altering maximal oxygen uptake. Diabetes Care. 1998; 21: 1353-5
|
|
|
|
|
|
5) Nader GA, Esser KA. Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. J Appl Physiol. 2001; 90: 1936-42
|
|
|
|
|
|
6) Izumiya Y, Hopkins T, Morris C, et al. Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab. 2008; 7: 159-72
|
|
|
|
|
|
7) Ullum H, Haahr PM, Diamant M, et al. Bicycle exercise enhances plasma IL–6 but does not change IL–1 alpha, IL–1 beta, IL–6, or TNF-alpha pre-mRNA in BMNC. J Appl Physiol. 1994; 77: 93-7
|
|
|
|
|
|
8) Ostrowski K, Rohde T, Zacho M, et al. Evidence that Interleukin–6 is produced in human skeletal muscle during prolonged running. J Physiol. 1998; 508 Pt 3: 949-53
|
|
|
|
|
|
9) Jonsdottir IH, Schjerling P, Ostrowski K, et al. Muscle contractions induce Interleukin–6 mRNA production in rat skeletal muscles. J Physiol. 2000; 528 Pt 1: 157-63
|
|
|
|
|
|
10) Steensberg A, van Hall G, Osada T, et al. Production of Interleukin–6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma Interleukin–6. J Physiol. 2000; 529 Pt 1: 237-42
|
|
|
|
|
|
11) Carey AL, Steinberg GR, Macaulay SL, et al. Interleukin–6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006; 55: 2688-97
|
|
|
|
|
|
12) Weigert C, Hennige AM, Brodbeck K, et al. Interleukin–6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt. Am J Physiol Endocrinol Metab. 2005; 289: E251-7
|
|
|
|
|
|
13) Senn JJ, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 (SOCS–3), a potential mediator of Interleukin–6-dependent insulin resistance in hepatocytes. J Biol Chem. 2003; 278: 13740-6
|
|
|
|
|
|
14) Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a T cell growth factor that interacts with the beta chain of the Interleukin–2 receptor. Science. 1994; 264: 965-8
|
|
|
|
|
|
15) Riechman SE, Balasekaran G, Roth SM, et al. Association of interleukin–15 protein and interleukin–15 receptor genetic variation with resistance exercise training responses. J Appl Physiol. 2004; 97: 2214-9
|
|
|
|
|
|
16) Furmanczyk PS, Quinn LS. Interleukin–15 increases myosin accretion in human skeletal myogenic cultures. Cell Biol Int. 2003; 27: 845-51
|
|
|
|
|
|
17) Quinn LS, Anderson BG, Strait-Bodey L, et al. Oversecretion of interleukin–15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab. 2009; 296: E191-202
|
|
|
|
|
|
18) Quinn LS, Strait-Bodey L, Anderson BG, et al. Interleukin–15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol Int. 2005; 29: 449-57
|
|
|
|
|
|
19) Nieman DC, Henson DA, Smith LL, et al. Cytokine changes after a marathon race. J Appl Physiol. 2001; 91: 109-14
|
|
|
|
|
|
20) Akerstrom T, Steensberg A, Keller P, et al. Exercise induces interleukin–8 expression in human skeletal muscle. J Physiol. 2005; 563 Pt 2: 507-16
|
|
|
|
|
|
21) Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin–8 as a macrophage-derived mediator of angiogenesis. Science. 1992; 258: 1798-801
|
|
|
|
|
|
22) Frydelund-Larsen L, Penkowa M, Akerstrom T, et al. Exercise induces interleukin–8 receptor (CXCR2) expression in human skeletal muscle. Exp Physiol. 2007; 92: 233-40
|
|
|
|
|
|
23) Nedachi T, Fujita H, Kanzaki M. Contractile C2C12 myotube model for studying exercise-inducible responses in skeletal muscle. Am J Physiol Endocrinol Metab. 2008; 295: E1191-204
|
|
|
|
|
|
24) Broholm C, Mortensen OH, Nielsen S, et al. Exercise induces expression of leukaemia inhibitory factor in human skeletal muscle. J Physiol. 2008; 586: 2195-201
|
|
|
|
|
|
25) Matthews VB, Astrom MB, Chan MH, et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia. 2009; 52: 1409-18
|
|
|
|
|
|
26) Tateno K, Minamino T, Toko H, et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res. 2006; 98: 1194-202
|
|
|
|
|
|
27) Mortensen OH, Andersen K, Fischer C, et al. Calprotectin is released from human skeletal muscle tissue during exercise. J Physiol. 2008; 586: 3551-62
|
|
|
|
|
|
28) Nishizawa H, Matsuda M, Yamada Y, et al. Musclin, a novel skeletal muscle-derived secretory factor. J Biol Chem. 2004; 279: 19391-5
|
|
|
|
|
|
29) Kita S, Nishizawa H, Okuno Y, et al. Competitive binding of musclin to natriuretic peptide receptor 3 with atrial natriuretic peptide. J Endocrinol. 2009; 201: 287-95
|
|
|
|
|
|
30) Takahashi A, Kureishi Y, Yang J, et al. Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol Cell Biol. 2002; 22: 4803-14
|
|
|
|
|
|
31) Birot OJ, Koulmann N, Peinnequin A, et al. Exercise-induced expression of vascular endothelial growth factor mRNA in rat skeletal muscle is dependent on fibre type. J Physiol. 2003; 552 Pt 1: 213-21
|
|
|
|
|
|
32) Bryan BA, Walshe TE, Mitchell DC, et al. Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation. Mol Biol Cell. 2008; 19: 994-1006
|
|
|
|
|
|
33) Aizawa K, Iemitsu M, Maeda S, et al. Expression of steroidogenic enzymes and synthesis of sex steroid hormones from DHEA in skeletal muscle of rats. Am J Physiol Endocrinol Metab. 2007; 292: E577-84
|
|
|
|
|
|
34) Aizawa K, Iemitsu M, Otsuki T, et al. Sex differences in steroidogenesis in skeletal muscle following a single bout of exercise in rats. J Appl Physiol. 2008; 104: 67-74
|
|
|
|
|
|
35) Kharitonenkov A, Shanafelt AB. Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases. BioDrugs. 2008; 22: 37-44
|
|
|
|
|
|
36) Izumiya Y, Bina HA, Ouchi N, et al. FGF21 is an Akt-regulated myokine. FEBS Lett. 2008; 582: 3805-10
|
|
|
|
|
|
37) Ouchi N, Oshima Y, Ohashi K, et al. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J Biol Chem. 2008; 283: 32802-11
|
|
|
|
|
|
38) Oshima Y, Ouchi N, Sato K, et al. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation. 2008; 117: 3099-108
|
|
|
|
|